Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis

Biochemical and Biophysical Research Communications

Volumn 371, Issue 3, 2008, Pages 441-445

  Pusl, Thomas ^a   Wild, Nadine ^a   Vennegeerts, Timo ^a   Wimmer, Ralf ^a   Göke, Burkhard ^a   Brand, Stephan ^a   Rust, Christian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Apoptosis; Bile acid; Cholestasis; Glycochenodeoxycholic acid; Interleukin; Liver; Nonalcoholic; Oleic acid; Steatosis

Indexed keywords

CASPASE 3; CASPASE 7; GLYCOCHENODEOXYCHOLIC ACID; INTERLEUKIN 22; INTERLEUKIN 8; OLEIC ACID; PALMITIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CHOLESTASIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL; LIVER INJURY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SENSITIZATION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELLS, CULTURED; FATS; FATTY ACIDS, NONESTERIFIED; GLYCOCHENODEOXYCHOLIC ACID; HEPATOCYTES; HUMANS; OLEIC ACID; PALMITIC ACID; RATS; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 43549115442     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.113     Document Type: Article

References (42)

1. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., Grundy S.M., and Hobbs H.H. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
2. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
3. Marchesini G., and Marzocchi R. Metabolic syndrome and NASH. Clin. Liver Dis. 11 (2007) 105-117 ix
4. Ong J.P., and Younossi Z.M. Epidemiology and natural history of NAFLD and NASH. Clin. Liver Dis. 11 (2007) 1-16 vii
5. Parekh S., and Anania F.A. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology 132 (2007) 2191-2207
6. Araya J., Rodrigo R., Videla L.A., Thielemann L., Orellana M., Pettinelli P., and Poniachik J. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin. Sci. (Lond.) 106 (2004) 635-643
7. Feldstein A.E., Canbay A., Angulo P., Taniai M., Burgart L.J., Lindor K.D., and Gores G.J. Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125 (2003) 437-443
8. Malhi H., Bronk S.F., Werneburg N.W., and Gores G.J. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J. Biol. Chem. 281 (2006) 12093-12101
9. Day C.P., and James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 (1998) 842-845
10. Hofmann A.F. Cholestatic liver disease: pathophysiology and therapeutic options. Liver 22 Suppl. 2 (2002) 14-19
11. Koga H., Sakisaka S., Ohishi M., Sata M., and Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 25 (1997) 1077-1084
12. Rodrigues C.M., Fan G., Wong P.Y., Kren B.T., and Steer C.J. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol. Med. 4 (1998) 165-178
13. Rust C., Karnitz L.M., Paya C.V., Moscat J., Simari R.D., and Gores G.J. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J. Biol. Chem. 275 (2000) 20210-20216
14. Sokol R.J., Straka M.S., Dahl R., Devereaux M.W., Yerushalmi B., Gumpricht E., Elkins N., and Everson G. Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids. Pediatr. Res. 49 (2001) 519-531
15. Graf D., Kurz A.K., Fischer R., Reinehr R., and Haussinger D. Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. Gastroenterology 122 (2002) 1411-1427
16. Higuchi H., Yoon J.H., Grambihler A., Werneburg N., Bronk S.F., and Gores G.J. Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis. J. Biol. Chem. 278 (2003) 454-461
17. Kobak G.E., Dahl R., Devereaux M.W., Gumpricht E., Traber M., Doctor R.B., and Sokol R.J. Increased susceptibility of fat-laden Zucker-rat hepatocytes to bile acid-induced oncotic necrosis: an in vitro model of steatocholestasis. J. Lab. Clin. Med. 145 (2005) 247-262
18. Soden J.S., Devereaux M.W., Haas J.E., Gumpricht E., Dahl R., Gralla J., Traber M.G., and Sokol R.J. Subcutaneous vitamin E ameliorates liver injury in an in vivo model of steatocholestasis. Hepatology 46 (2007) 485-495
19. Beuers U., Probst I., Soroka C., Boyer J.L., Kullak-Ublick G.A., and Paumgartner G. Modulation of protein kinase C by taurolithocholic acid in isolated rat hepatocytes. Hepatology 29 (1999) 477-482
20. Glasova H., Berghaus T.M., Kullak-Ublick G.A., Paumgartner G., and Beuers U. Tauroursodeoxycholic acid mobilizes alpha-PKC after uptake in human HepG2 hepatoma cells. Eur. J. Clin. Invest. 32 (2002) 437-442
21. Brand S., Dambacher J., Beigel F., Zitzmann K., Heeg M.H., Weiss T.S., Prufer T., Olszak T., Steib C.J., Storr M., Goke B., Diepolder H., Bilzer M., Thasler W.E., and Auernhammer C.J. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2007) G1019-G1028
22. Gomez-Lechon M.J., Donato M.T., Martinez-Romero A., Jimenez N., Castell J.V., and O'Connor J.E. A human hepatocellular in vitro model to investigate steatosis. Chem. Biol. Interact. 165 (2007) 106-116
23. Maedler K., Spinas G.A., Dyntar D., Moritz W., Kaiser N., and Donath M.Y. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 50 (2001) 69-76
24. Listenberger L.L., Han X., Lewis S.E., Cases S., Farese Jr. R.V., Ory D.S., and Schaffer J.E. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA 100 (2003) 3077-3082
25. Rodrigues C.M., Fan G., Ma X., Kren B.T., and Steer C.J. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101 (1998) 2790-2799
26. Faubion W.A., Guicciardi M.E., Miyoshi H., Bronk S.F., Roberts P.J., Svingen P.A., Kaufmann S.H., and Gores G.J. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Invest. 103 (1999) 137-145
27. Antonsson B., Montessuit S., Sanchez B., and Martinou J.C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276 (2001) 11615-11623
28. Reinehr R., Graf D., and Haussinger D. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 125 (2003) 839-853
29. Tsuchiya S., Tsuji M., Morio Y., and Oguchi K. Involvement of endoplasmic reticulum in glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes. Toxicol. Lett. 166 (2006) 140-149
30. Bernt C., Vennegeerts T., Beuers U., and Rust C. The human transcription factor AP-1 is a mediator of bile acid-induced liver cell apoptosis. Biochem. Biophys. Res. Commun. 340 (2006) 800-806
31. Andoh A., Zhang Z., Inatomi O., Fujino S., Deguchi Y., Araki Y., Tsujikawa T., Kitoh K., Kim-Mitsuyama S., Takayanagi A., Shimizu N., and Fujiyama Y. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129 (2005) 969-984
32. Yasumoto K., Okamoto S., Mukaida N., Murakami S., Mai M., and Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 267 (1992) 22506-22511
33. Thornton A.J., Strieter R.M., Lindley I., Baggiolini M., and Kunkel S.L. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. J. Immunol. 144 (1990) 2609-2613
34. Kugelmas M., Hill D.B., Vivian B., Marsano L., and McClain C.J. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 38 (2003) 413-419
35. Bahcecioglu I.H., Yalniz M., Ataseven H., Ilhan N., Ozercan I.H., Seckin D., and Sahin K. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. Hepatogastroenterology 52 (2005) 1549-1553
36. Joshi-Barve S., Barve S.S., Amancherla K., Gobejishvili L., Hill D., Cave M., Hote P., and McClain C.J. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46 (2007) 823-830
37. Lejeune D., Dumoutier L., Constantinescu S., Kruijer W., Schuringa J.J., and Renauld J.C. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol. Chem. 277 (2002) 33676-33682
38. Dumoutier L., Van Roost E., Colau D., and Renauld J.C. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. USA 97 (2000) 10144-10149
39. Radaeva S., Sun R., Pan H.N., Hong F., and Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39 (2004) 1332-1342
40. Pan H., Hong F., Radaeva S., and Gao B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell. Mol. Immunol. 1 (2004) 43-49
41. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Karow M., and Flavell R.A. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27 (2007) 647-659
42. Horiguchi N., Wang L., Mukhopadhyay P., Park O., Jeong W.I., Lafdil F., Osei-Hyiaman D., Moh A., Fu X.Y., Pacher P., Kunos G., and Gao B. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134 (2008) 1148-1158